standard]
MGSSSSGGGGNDSSHLQLLSSLISSEESERKFLLNFYDHAFKGFSAMLTE
NEASVLSGYDEVLSVFPDPVLKLHTTRSWDFLEAADSKFGSRFPYERSSS
DVIIGIIDTGIWPESPSFDDQHISKIPSKWKGVCMEGSDFKKSNCNRKLI
GARFYSNRDISKKRNETSPTQSHGSPRDFVGHGTHTASTAGGVAVANASY
YGLARGTARGGLPSARIASYKACTLDGCPGSIILKAIDDAIKDGVDIISI
SIGVSSIFQSDFLNDPIAIGAFHAEQMGVPVVCSGGNDGPDPYTIVNSAP
WIFTVAASSIDRDFQSTIVLGNNESYKGSAISFSPLTLGKRYPLAFGEEV
AANFTPASDARNCIPGSLDPKKVAGKIIVCMNDEPNVSRRIKKLVVEDAK
AEGVIIIDGERETSPFDSGTYPFAEVGQTVGSKILRYINSTWNPVATILP
SSEIRNFKPAPVVASFSSRGPGALTENILKPDIMAPGVAILAAVVPKIES
FYGAPGNKSSLFSIKSGTSMACPHVTGAMAFIKSVHPHWTFSLIKSALIT
TASVSNNMGKTLTNTSDSSANPHQVGAGEIRPIKALDPGLAFDTTINDHL
NFLCYYGYKQERLRSMSNTNFTCPKHSTEELISNINYPTISIGRLSQHDG
PRKVKRIATNVGSTNATYVSSVNAPPGLVVNVVPKRLVFTQGIRRASFKV
FFDGKEASKGYNFGDIRWFDGSHLVRIVFAVNIE
|
IPR000209; Peptidase S8/S53, subtilisin/kexin/sedolisin IPR003137; Protease-associated domain, PA IPR010259; Proteinase inhibitor I9, subtilisin propeptide IPR022398; Peptidase S8/S53, subtilisin, act |